320 related articles for article (PubMed ID: 32782479)
1. Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals.
Comarmond C; Cacoub P; Saadoun D
Therap Adv Gastroenterol; 2020; 13():1756284820942617. PubMed ID: 32782479
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
[TBL] [Abstract][Full Text] [Related]
4. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Bonacci M; Lens S; Londoño MC; Mariño Z; Cid MC; Ramos-Casals M; Sánchez-Tapias JM; Forns X; Hernández-Rodríguez J
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Cryoglobulinemias.
Fuentes A; Mardones C; Burgos PI
Curr Rheumatol Rep; 2019 Nov; 21(11):60. PubMed ID: 31741077
[TBL] [Abstract][Full Text] [Related]
6. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D
Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688
[TBL] [Abstract][Full Text] [Related]
9. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
[TBL] [Abstract][Full Text] [Related]
10. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.
Passerini M; Schiavini M; Magni CF; Landonio S; Niero F; Passerini S; Croci AL; Bolis M; Scalzi V; Gubertini G; Ricci ED; Galli M; Rizzardini G
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1208-1215. PubMed ID: 30138160
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
12. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
13. Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals.
Barbieri D; García-Prieto A; Torres E; Verde E; Goicoechea M; Luño J
Clin Kidney J; 2019 Jun; 12(3):362-364. PubMed ID: 31198535
[TBL] [Abstract][Full Text] [Related]
14. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?
Bunchorntavakul C; Mitrani R; Reddy KR
J Clin Exp Hepatol; 2018 Mar; 8(1):81-94. PubMed ID: 29743799
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.
Aguiar MF; Faria-Janes AL; Garcia-Brandes GI; Takemi-Emori C; Ferraz MLG; Andrade LEC; de Souza AWS
Ann Hepatol; 2019; 18(5):685-692. PubMed ID: 31167733
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
18. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
Dammacco F; Racanelli V; Russi S; Sansonno D
Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
[TBL] [Abstract][Full Text] [Related]
19. Extrahepatic manifestations of HCV where do we stand?
Mokhles MA
Med Clin (Barc); 2024 Mar; 162(5):231-237. PubMed ID: 37980213
[TBL] [Abstract][Full Text] [Related]
20. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
